Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Squamous Cell Carcinoma of Head and Neck 2Oropharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Carcinoma 1

Interventions

Cisplatin 76Cetuximab 60pembrolizumab 56Radiotherapy, Intensity-Modulated 37Radiotherapy 33Carboplatin 31Docetaxel 30Fluorouracil 27Nivolumab 26Paclitaxel 20Platinum 10Albumin-Bound Paclitaxel 9Surgical Procedures, Operative 8Radiosurgery 8Radiation 8Erlotinib Hydrochloride 8durvalumab 7Bevacizumab 71,2-diaminocyclohexaneplatinum II citrate 7epacadostat 6Biopsy 6Radiotherapy, Conformal 5Ipilimumab 5Immunoglobulin G 5Gemcitabine 5Capecitabine 5130-nm albumin-bound paclitaxel 5utomilumab 4tremelimumab 4palbociclib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Squamous Cell Carcinoma of Head and Neck × (225)Ac-DOTA-c(RGDyK) × Clear all
NCT03258554 2026-06-02

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

National Cancer Institute (NCI)

Phase 2/3 Completed
196 enrolled 31 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT01468896 2026-04-29

Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 1/2 Active not recruiting
23 enrolled 11 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡